Mustang Bio Q3 EPS $(1.23) Misses $(1.11) Estimate
Portfolio Pulse from Benzinga Newsdesk
Mustang Bio (NASDAQ:MBIO) reported a Q3 EPS loss of $(1.23), which did not meet the analyst consensus estimate of $(1.11), missing by 10.81%. However, this represents a 54.44% improvement from the $(2.70) per share loss reported in the same quarter of the previous year.
November 14, 2023 | 10:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Mustang Bio reported a larger-than-expected Q3 loss per share of $(1.23), missing the $(1.11) estimate, but improved from last year's $(2.70) loss.
Missing the EPS estimate is likely to negatively impact investor sentiment in the short term, despite the year-over-year improvement in losses. Investors typically react unfavorably to earnings misses, which can lead to a decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100